Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
T1SmUhAkNHf1bUMM
Listen
